How They Make Money

How They Make Money

Share this post

How They Make Money
How They Make Money
πŸ“Š PRO: This Week in Visuals
Copy link
Facebook
Email
Notes
More

πŸ“Š PRO: This Week in Visuals

PG, JNJ, AXP, ISRG, TXN, VZ, SCHW, GEV, UAL, AAL

App Economy Insights's avatar
App Economy Insights
Jan 25, 2025
βˆ™ Paid
38

Share this post

How They Make Money
How They Make Money
πŸ“Š PRO: This Week in Visuals
Copy link
Facebook
Email
Notes
More
2
Share

Welcome to the Saturday PRO edition of How They Make Money.

Over 170,000 subscribers turn to us for business and investment insights.

In case you missed it:

  • 🍿 Netflix: Biggest Quarter Ever

  • πŸ“± AppLovin: The Next Ad Tech Giant?


Our PRO coverage includes timely updates on the recent big earnings.

  • πŸ“§ Free subscribers get our Friday articles and sneak peeks.

  • πŸ’Œ Premium subscribers get:

    • Tuesday articles.

    • Access to our archive.

    • Monthly reports with 200+ companies covered.

  • πŸ’Ό PRO members get all of the above, plus our Saturday coverage.


Today at a glance:

  1. 🧴 Procter & Gamble: Volume Boost

  2. πŸ’Š Johnson & Johnson: MedTech Weakness

  3. πŸ’³ American Express: Holiday Tailwind

  4. 🦾 Intuitive Surgical: Surging Growth

  5. βš™οΈ Texas Instrument: Sluggish Demand

  6. πŸ“± Verizon: Broadband Momentum

  7. 🏦 Charles Schwab: Record Inflows

  8. ⚑ GE Vernova: Record Orders

  9. πŸ›©οΈ United Airlines: Demand Takes Off

  10. πŸ¦… American Airlines: Corporate Rebuild


1. 🧴 Procter & Gamble: Volume Boost

In its December quarter (Q2 FY25), Procter & Gamble’s revenue grew 2% Y/Y to $21.9 billion ($310 million beat), with an adjusted EPS of $1.88 ($0.02 beat). Organic sales rose 3% Y/Y. For the first time since 2019, pricing was flat Y/Y, while organic volume increased 2%, led by healthcare, grooming, and home careβ€”though China’s slowdown weighed on beauty sales.

Despite inflation concerns, consumers are trading upβ€”opting for premium products and bulk sizes, reinforcing P&G’s pricing power and brand strength. The company reaffirmed its FY25 guidance of 2-4% revenue growth and EPS between $6.91 and $7.05. The challenge now is sustaining volume growth of its essentials, from Gilette razors to Tide detergent, as the boost from pricing fades.


2. πŸ’Š Johnson & Johnson: MedTech Weakness

This post is for subscribers in the PRO Member plan

Already in the PRO Member plan? Sign in
Β© 2025 App Economy Insights LLC
Privacy βˆ™ Terms βˆ™ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More